The company have significantly advanced the progress of a new solution for cardiac amyloidosis, leveraging the compound. Initial clinical data suggests promising outcomes for those suffering by this serious disease. https://bridgebio100698.blogzet.com/bridgebio-advances-attr-cm-management-with-attruby-57255632